1-1 of 1
Thiago Di Matteo, Clinical Study Coordinator
Close
Save search
Sort by
Journal Articles

Clinical Pharmacokinetic (PK) and Safety (Immunogenicity) of Rituximab Biosimilar RTXM83 in Combination with Chemotherapy CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Free
Amalia Florez, Clinical Study Coordinator, Thiago Di Matteo, Clinical Study Coordinator, Gloria Fresnillo, Regulatory Affairs- Biotech Division, Consuelo Tudela, Preclinical Study Coordinator, Mauricio Seigelchifer, Scientific Director, Esteban Corley, Director, Analia Pesce, QA Director, Cedric Bes, Research & Development Director, Susana Millan, PhD MDcal Director
Journal: Blood
Blood (2014) 124 (21): 5472.
https://doi.org/10.1182/blood.V124.21.5472.5472
Published: 2014